GALECTIN THERAPEUTICS INC(GALT)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

GALECTIN THERAPEUTICS INC (GALT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. GALT is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of GALT by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. GALT trades on the Nasdaq exchange and files with the SEC under CIK 1133416. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GALT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GALECTIN THERAPEUTICS INC directly from SEC EDGAR.

Net Income

$-9.1M

Institutions holding GALT

Institutional investors reporting a position in GALECTIN THERAPEUTICS INC on SEC Form 13F.
InstitutionSharesValueReported
BlackRock2,988,353$13.9M2026-06-30
VANGUARD CAPITAL MANAGEMENT2,168,065$10.1M2026-06-30
GEODE CAPITAL MANAGEMENT1,308,394$6.1M2026-06-30
OSAIC1,203,725$5.6M2026-06-30
MARSHALL WACE, LLP831,010$3.9M2026-06-30
GREAT POINT PARTNERS800,000$3.7M2026-06-30
Wealthspire Advisors721,788$3.3M2026-06-30
STATE STREET567,779$2.6M2026-06-30
COMMONWEALTH EQUITY SERVICES407,113$1.9M2026-06-30
NORTHERN386,545$1.8M2026-06-30
SEC EDGAR: CIK 1133416 →
GALT

GALECTIN THERAPEUTICS INC

GALT
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$-9.11M

EPS (Diluted)

Q2 2026
EDGAR

$-0.14

Top Institutional Holders

as of Q2 2026
$79.41M total
BlackRock, Inc.
$13.87M+273.9%
VANGUARD CAPITAL MANAGEMENT LLC
$10.06M+10.2%
GEODE CAPITAL MANAGEMENT, LLC
$6.07M+113.5%
OSAIC HOLDINGS, INC.
$5.59M+7.2%
MARSHALL WACE, LLP
$3.86M-31.9%
GREAT POINT PARTNERS LLC
$3.71M0.0%
Wealthspire Advisors, LLC
$3.35M0.0%
STATE STREET CORP
$2.63M+119.7%
COMMONWEALTH EQUITY SERVICES, LLC
$1.89M+10.9%
NORTHERN TRUST CORP
$1.79M+196.3%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…